Impax Asset Management Group
CELG

Impax Asset Management Group’s Celgene Corp CELG Stock Holding History

Impax Asset Management Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-71,168
Closed -$7.07M – 318
2019
Q3 		$7.07M Hold
71,168
– – 0.09% 142
2019
Q2 		$6.58M Sell
71,168
-35,504
-33% -$3.37M 0.09% 141
2019
Q1 		$10.1M Sell
106,672
-28,328
-21% -$2.48M 0.14% 116
2018
Q4 		$8.65M Buy
135,000
+34,000
+34% +$2.51M 0.14% 125
2018
Q3 		$9.04M Buy
+101,000
New +$8.93M 0.13% 136

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Impax Asset Management Group's CELG Position: Q4 2019 in Review

Impax Asset Management Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 71,168 shares — an estimated $7.07M sold.

Impax Asset Management Group first reported a position in CELG in Q3 2018 and held it in 5 quarters. The position peaked at $10.1M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Impax Asset Management Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Impax Asset Management Group sold 71,168 Celgene Corp shares in Q4 2019, an estimated $7.07M.
  • Impax Asset Management Group first reported a position in Celgene Corp in Q3 2018 and held it in 5 quarters.
  • Impax Asset Management Group's Celgene Corp position peaked at $10.1M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Impax Asset Management Group's 13F filing for Q4 2019, filed 13 Feb 2020.